Jeffrey Switchenko

29PUBLICATIONS
163CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 07, 2026
Blueberry Extract Has Anti-Proliferative Activity in Preclinical Models of Head and Neck Cancer.

|Aug 15, 2026
Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

|Jul 08, 2026
Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms.

|Feb 17, 2026
Receipt of guideline-concordant local and chemotherapy-based systemic therapy for patients with triple-negative breast cancer: 10-year survival outcomes in a multi-state population-based analysis.

Joseph Lipscomb, Gretchen G Kimmick, J Frank Wilson

|May 12, 2025
Early-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer.

Nicole C Schmitt, William A Stokes, James E Bates

|Jul 07, 2023
Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.

Chloe S Lalonde, Jeffrey M Switchenko, Madhusmita Behera

Pageof 5

Frequent Collaborators

6 joint publications

Jonathon Cohen

6 joint publications

Brad S Kahl

5 joint publications

Nabil F Saba

4 joint publications

Rajesh Valanparambil